Huiyan Li
- Cancer Research top 5%
- NF-κB Signaling Pathways 4
- Immunology top 10%
- interferon and immune responses 5
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 10
- PI3K/AKT/mTOR signaling in cancer 4
- Nephrology top 5%
- Cell Biology top 10%
- Microtubule and mitosis dynamics 6
-
- Genetic and Kidney Cyst Diseases 5
- Ocular Disorders and Treatments 4
-
- Cancer-related Molecular Pathways 4
- Journals
- Nature Communications (4 papers)Journal of Biological Chemistry (3 papers)Journal of Zhejiang University SCIENCE B (2 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Huiyan Li
54 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 311
- Immunology 404
- Molecular Biology 1.3k
- Nephrology 119
- Cell Biology 196
Countries citing papers authored by Huiyan Li
This map shows the geographic impact of Huiyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiyan Li more than expected).
Fields of papers citing papers by Huiyan Li
This network shows the impact of papers produced by Huiyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiyan Li. The network helps show where Huiyan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huiyan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 61 | |
| 9 | 2019 | 113 | |
| 10 | 2017 | 65 | |
| 11 | 2016 | 38 | |
| 12 | 2014 | 22 | |
| 13 | 2013 | 9 | |
| 14 | 2010 | 58 | |
| 15 | 2008 | 10 | |
| 16 | 2008 | 115 | |
| 17 | 2007 | 6 | |
| 18 | 2007 | 60 | |
| 19 | 2006 | 28 | |
| 20 | 2004 | 111 |
About Huiyan Li
Huiyan Li is a scholar working on Immunology, Cell Biology and Cancer Research, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Microtubule and mitosis dynamics (6 papers), interferon and immune responses (5 papers), Genetic and Kidney Cyst Diseases (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer-related Molecular Pathways (4 papers), Ocular Disorders and Treatments (4 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Cancer Research (311 citations), Immunology (404 citations) and Molecular Biology (1.3k citations). Huiyan Li has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Tao Zhou, Ailing Li, Xuemin Zhang, Xin Pan, Xue-Min Zhang, Jiang-Hong Man, Tao Li, Wei-Li Gong, Jie Zhao and Qiuying Han. Their work appears in journals such as Nature Communications, Journal of Biological Chemistry, Journal of Zhejiang University SCIENCE B, Journal of Proteome Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.